Safety and efficacy of levetiracetam for patients with panic disorder: Results of an open-label, fixed-flexible dose study

Journal of Clinical Psychiatry

Volumn 67, Issue 10, 2006, Pages 1573-1576

  Papp, Laszlo A ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM;

ADULT; AGORAPHOBIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; IRRITABILITY; LIBIDO DISORDER; MALE; OPEN STUDY; ORGASM DISORDER; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 33751237676     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n1012     Document Type: Article

References (27)

1. Papp LA. Pharmacological management of anxiety and stress disorders. In: Lehrer PM, Woolfolk RL, eds. Principles and Practice of Stress Management. 3rd ed. New York, NY: Guilford Press; 2006. In press
2. McNamara M, Fogel B. Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities. J Neuropsychiatry Clin Neurosci 1990;2:193-196
3. Dantendorfer K, Amering M, Baischer W, et al. Is there a pathophysiological and therapeutic link between panic disorder and epilepsy? Acta Psychiatr Scand 1995;91:430-432
4. Dale MC. Distinguishing between partial seizures and panic attacks: psychotic and behavioral symptoms are also common in elderly patients. BMJ 2001;322:864
5. Araszkiewicz A, Rybakowski JK. Hoigne's syndrome, kindling and panic disorder. Depress Anxiety 1996;4:139-143
6. Post RM. Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms? Epilepsy Res 2002;50:203-219
7. Lydiard RB. The role of GABA in anxiety disorders. J Clin Psychiatry 2003;64(suppl 3):21-27
8. Tondo L, Burrai C, Scamonatti L, et al. Carbamazepine in panic disorder. Am J Psychiatry 1989;146:558-559
9. Keck PE Jr, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and postfraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992;12:36S-41S
10. Keck PE Jr, McElroy SL, Tugrul KC, et al. Antiepileptic drugs for the treatment of panic disorder. Neuropsychobiology 1993;27:150-153
11. Windhaber J, Maierhofer D, Dantendorfer K. Oxcarbazepine for panic disorder occurring after two grand mal seizures: a case report [letter]. J Clin Psychiatry 1997;58:404-405
12. Lum M, Fontaine R, Elie R, et al. Divalproex sodium's antipanic effect in panic disorder: a placebo-controlled study. Biol Psychiatry 1990;27:164-166
13. Leppik IE. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide. J Child Neurol 2002;17(suppl 1):S53-S57
14. Lamberty Y, Gower AJ, Klitgaard H. The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice. Eur J Pharmacol 2002;439:101-106
15. Lamberty Y Falter U, Gower AJ, et al. Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in the rat. Eur J Pharmacol 2003;469:97-102
16. Kinrys G, Wygant LE, Pardo TB, et al. Levetiracetam for treatment-refractory posttraumatic stress disorder. J Clin Psychiatry 2006;67:211-214
17. Simon NM, Worthington JJ, Doyle AC, et al. An open-label study of levetiracetam for the treatment of social anxiety disorder. J Clin Psychiatry 2004;65:1219-1222
18. Sheehan DV, Lecrubier Y, et al. Mini-International Neuropsychiatric Interview (MINI). Tampa, FIa: University of South Florida, Institute for Research in Psychiatry, and Paris, France: INSERM-Hôpital de la Salpêtrière; 1994
19. Bandelow B, Broocks A, Ruther E. The application of the panic and agoraphobia scale (PAS) in clinical trials. Eur Neuropsychopharmacol 1997;7(suppl 2):229-229(1)
20. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Panic Disorder. Am J Psychiatry 1998:155(suppl 5):1-34
21. Keppra (levetiracetam). Physicans' Desk Reference. 60th ed. Montvale, NJ: Thomson PDR; 2006:3311
22. French JA, Arrigo C. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 2005;46:324-326
23. Papp LA, Schneier FR, Fyer AJ, et al. Clomipramine treatment of panic disorder: pros and cons. J Clin Psychiatry 1997;58:423-425
24. Papp LA, Sinha S, Coplan JD, et al. Low dose venlafaxine treatment in panic disorder. Psychopharmacol Bull 1998;34:207-209
25. Papp LA. Somatic treatment of anxiety disorders. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. 7th ed. Baltimore, Md: Williams & Wilkins; 1999:1490-1498
26. French J, Edrich P, Cramer JA. A systematic review of the safety profile of levetiracetam, a new antiepileptic drug. Epilepsy Res 2001;47:77-90
27. Gorenstein EE, Kleber MS, Mohlman J, et al. Cognitive-behavioral therapy for management of anxiety and medication taper in older adults. Am J Geriatr Psychiatry 2005;13:901-909